The alliance encourages further research and production of ExtreMESH, a durable surgical mesh made from DSM’s Dyneema Purity high-performance polyethylene fiber technology.
The partnership, which is aimed at the development by Proxy Biomedical of new technologies to advance orthopaedic treatments, precedes the opening of the annual Orthopaedic Research Society conference.
DSM Dyneema Purity fiber business manager Carina Snijder said with new access to Proxy Biomedical’s expertise in high performance materials research, development and manufacturing, their ability to help those needing tissue repair or regeneration is expanding and they are always excited to get the chance to provide Dyneema Purity fiber for new uses.
Proxy Biomedical managing director Peter Gingras said the partnership will allow the development of new biomedical meshes and scaffolds where the demand for high strength, fatigue and abrasion resistance and low elongation is paralleled by the availability of virtual unlimited flexibility in mesh pore size, fiber diameter and weight.
